A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)

Satkunasivam, Raj (PI)
Butler, E. Brian (Key Personnel)
Chan, Keith Syson (Key Personnel)
Chen, Shu-Hsia (Key Personnel)
Esnaola, Nestor F. (Key Personnel)
Farach, Andrew M. (Key Personnel)
Teh, Bin S. (Key Personnel)
Zhang, Jun (Key Personnel)

Houston Methodist

Project: Clinical Trial

Status	Not started